CClinicalTrials.gg
CompletedNCT04281810Updated Feb 24, 2020

Transcutaneous Electrical Diaphragmatic Stimulation in PMV Patients

An interventional study of transcutaneous electric diaphragm stimulation in Mechanical Ventilation, sponsored by Chang Gung Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2020-02-24.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Apr 2017, registered Feb 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
59
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

Muscle atrophy and diaphragm dysfunction are common with prolonged mechanical ventilation (PMV). Electrical stimulation has been shown to be beneficial in severe chronic heart failure and chronic obstructive pulmonary disease. However, its effect on PMV is unclear. This study examined the effects of transcutaneous electrical diaphragmatic stimulation (TEDS) on respiratory muscle strength and weaning outcomes in patients with PMV.

Read the detailed description

Patients on ventilation for ≥21 days were randomly assigned to TEDS and control groups. The TEDS group received muscle electrical stimulation for 30 min/session/day throughout the intervention. Weaning parameters (tidal volume, respiratory rate, and rapid shallow breathing index) and respiratory muscle strength (Pimax, Pemax) were assessed. The hospitalization outcome, including weaning rate and length of stay, was followed up until discharge.

02

Conditions studied

  • Mechanical Ventilation

Keywords

  • electrical stimulation
  • diaphragmatic
  • weaning
  • respiratory muscle
03

In context

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥ 20 years;
  • MV for > 6 h/day for > 21 days;
  • Medical stability (PaO2 ≥ 60 mmHg at 40% FiO2, absence of signs and symptoms of infection, and hemodynamic stability).

Exclusion criteria

Exclusion Criteria:

  • Acute lung or systemic infection, hemodynamic instability, patients with pacemakers, abdominal distention, and pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
59 participants (actual)

Study arms

  • Experimental
    TEDS

    Subjects received transcutaneous electrical diaphragm stimulation (TEDS) for 30min/ day till the end of the weaning trial

    Device: transcutaneous electric diaphragm stimulation

  • No intervention
    Control

    Subjects received similar medical treatment except for the TEDS program.

Interventions

  • Devicetranscutaneous electric diaphragm stimulation

    The electrodes were placed on the parasternal region beside the xiphoid process; and the sixth and seventh intercostal spaces in line with the mid-axillary line. TEDS was set as biphasic waves, frequency of 30 Hz, pulse width of 400 μs, and rise time of 0.7s.

06

What researchers measure

Primary outcomes

  1. tidal volume

    The tidal volume was measured by a spirometer

    Time frame: 1st day of intervention

  2. tidal volume

    The tidal volume was measured by a spirometer

    Time frame: through study completion,an average of 4 weeks

  3. rapid shallow breathing index

    respiratory rate/tidal volume

    Time frame: 1st day of intervention

  4. rapid shallow breathing index

    respiratory rate/tidal volume

    Time frame: through study completion,an average of 4 weeks

  5. respiratory muscle strength (maximal inspiratory pressure)

    pressure gauge

    Time frame: the 1st day of intervention

  6. respiratory muscle strength (maximal expiratory pressure)

    pressure gauge

    Time frame: the 1st day of intervention

  7. respiratory muscle strength (maximal inspiratory pressure)

    pressure gauge

    Time frame: through study completion,an average of 4 weeks

  8. respiratory muscle strength (maximal expiratory pressure)

    pressure gauge

    Time frame: through study completion,an average of 4 weeks

Secondary outcomes

  1. weaning rate

    ventilator weaning results (weaning successful/failure)

    Time frame: through study completion,an average of 7 weeks

  2. length of stay in respiratory care center

    the total days of stay in respiratory care center

    Time frame: through study completion,an average of 7 weeks

07

Study locations

1 site
  • Chang Gung University
    TaoYuan City, Tao-Yuan 333, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04281810
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Feb 24, 2020
Start date
Apr 20, 2017
Primary completion
Sep 29, 2018
Completion
Jul 25, 2019
Last update
Feb 24, 2020

Study contacts

Yi-Fei Hsin
principal investigator · Chang Gung Memorial Hospital
Yen-Huey Chen
study director · Chang Gung University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion